, Volume 4, Issue 1–2, pp 7–48 | Cite as

Lactulose: A Review of its Therapeutic and Pharmacological Properties with particular reference to ammonia metabolism and its mode of action in portal systemic encephalopathy

  • G. S. Avery
  • Elizabeth F. Davies
  • R. N. Brogden
Evaluations on New Drugs


Synopsis: Lactulose is a synthetic derivative of lactose which does not occurnaturally. It contains one molecule of galactose and one molecule of fructose and as a 50 % w/w syrup2 is advocated for the treatment of portal systemic encephalopathy and chronic constipation.

Following oral administration, lactulose reaches the colon virtually unchanged, where it is broken down by saccharolytic bacteria. There is no specific lactulase enzyme in the small intestine of man to hydrolyse the sugar. Little of the ingested dose is Key Words absorbed. It appears that its most likely mode of action in both portal systemic encephalopathy and in constipation is primarily due to acidification of the colonic contents, presumably by the organic acids (mainly lactic acid) formed following the bacterial hydrolysis of lactulose in the colon. In portal systemic encephalopathy it is tempting to believe that such an action might be associated with a decrease in the relative concentration of free ammonia, the major aetiological agent involved in the cerebral disturbance. Reversal of abnormal cerebral energy metabolism and improved ammonia tolerance has been demonstrated following lactulose administration in patients with portal systemic encephalopathy. An osmotic effect from the organic acid breakdown products of lactulose probably explains the laxative action in chronic constipation.

The majority of patients with chronic portal systemic encephalopathy respond to lactulose, on the basis of clinical and EEG evidence of improvement, and decrease in blood ammonia levels; provided it is given in an appropriate dosage and tolerated by the patient. A response has occurred in those with a portacaval shunt and in those who had been unsuccessfully managed on standard forms of therapy. Some patients however, may not respond to lactulose and others may respond better to neomycin. Failures of treatment appear to occur in preterminal patients or in those with mild symptoms of encephalopathy. Where successful, lactulose can be given on a long-term basis to prevent a recurrence of encephalopathy and can sometimes enable an increase in protein intake or intellectual activity. Although lactulose has been successful in chronic constipation, any practical superiority over conventional laxatives has yet to be established. Abdominal complaints and flatulence may occur during the early stages of treatment. In portal systemic encephalopathy, diarrhoea (and possibly hypokalaemia) is evidence of overdosage and should be avoided.


Ammonia metabolism: cerebral Ammonia transport: colonic Constipation Encephalopathy, hepatic: energy metabolism Encephalopathy, hepatic: pathogenesis Encephalopathy, portal systemic Lactulose Urea metabolism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bircher, J.; Gmunder, U.; Haemmerli, U.P.; Müller-Duysing, W.; Bally, G.; Haemmerli, G. and Hoffmann, K.: Zum Wirkungmechanismus der Lactulose beim Coma hepaticum — Abklärung der Ureaseaktivitat im Colon mittels 14C-Harnstoff bei Ratten. Strahlentherapie 67: 330 (1968)Google Scholar
  2. Bircher, J.; Haemmerli, U.P.; Müller-Duysing, W.; Bally, G.; Haemmerli, G. and Hoffmann, K.: The mechanism of action of lactulose in portal-systemic encephalopathy: Colonic bacterial urease activity and bacterial flora in rats. Revue Européene d’Études Cliniques et Biologiques 15:1096(1970)Google Scholar
  3. Bircher, J.; Haemmerli, U.P.; Scollo-Lavizzari, G. and Hoffmann, K.: Treatment of chronic portal-systemic encephalopathy with lactulose. American Journal of Medicine 51.148(1971b).PubMedCrossRefGoogle Scholar
  4. Bircher, J.; Haemmerli, U.P.; Trabert, E.; Largiader, F. and Mocetti, T.: The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon. Revue Européene d’Études Cliniques et Biologiques 16: 352(1971a).Google Scholar
  5. Bircher, J.; Haemmerli, U.P. and Williams, R.: Lactulose in the treatment of portal-systemic encephalopathy. Gastroenterology 58: 595 (1969b).Google Scholar
  6. Bircher, J.; Hoffmann, K. and Haemmerli, U.P.: Short-term effects of lactulose in the colon, correlation of fecal pH, ammonia and bacterial flora, in Symposium on Lactulose, Baden/Vienna (September 8,1969a).Google Scholar
  7. Bircher, J.; Müller, J.; Guggenheim, P. and Haemmerli, U.P.: Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1:890 (1966)PubMedGoogle Scholar
  8. Braun, O.H.: The influence of lactulose on the intestinal lysocym excretion and intestinal flora of infants, in Symposium on Lactulose, Baden/Vienna (September 8, 1969)Google Scholar
  9. Brown, H; Trey, C. and McDermott, W.V.: Encephalopathy after portacaval shunting managed with lactulose. American Journal of Surgery 119:132(1970)PubMedCrossRefGoogle Scholar
  10. Brown, H.; Trey, C. and McDermott, W.V.: Lactulose treatment of hepatic encephalopathy in outpatients. Archives of Surgery 102: 25 (1971)PubMedCrossRefGoogle Scholar
  11. Bush, R.T.: Lactulose: An ideal laxative for children. New Zealand Medical Journal 71: 364(1970)PubMedGoogle Scholar
  12. Castell, D.O. and Moore, E.W.: Ammonia absorption from the human colon. The role of nonionic diffusion. Gastroenterology 60: 33 (1971)PubMedGoogle Scholar
  13. Colombo, J.P.: Congenital disorders of the urea cycle and ammonia intoxication, in Falkner, Kretchner and Rossi Monographs in Paediatrics, Vol. 1 (Karger, Basel 1971)Google Scholar
  14. Conn, H.O. and Floch, M.H.: Effects of lactulose and Lactobacillus acidophilus on the fecal flora. American Journal of Clinical Nutrition 23:1588 (1970)PubMedGoogle Scholar
  15. Dahlqvist, A. and Gryboski, Joyce D.: Inability of the human small-intestinal lactase to hydrolyze lactulose. Biochimica et Biophysica Acta 110: 635 (1965)CrossRefGoogle Scholar
  16. Demeulenaere, L.; Rottiers, R.; Egmond, J.van; Lacres, R.; Gierick, G. and Verbruggen, R.: Lactulose treatment of spontaneous or induced paroxysmal hyperammoniemia and of chronic hyperammoniemia in the cirrhotic patient, in Problemes de reanimation 5e serie: 855 (1969)Google Scholar
  17. Demeulenaere, L.; van Hee, W.; Lacres, R. and van Egmond, J.: Lactulose and ammonia tolerance, in Symposium of Lactulose, Baden/Vienna (September 8, 1969)Google Scholar
  18. Elkington, S.G.; Floch, MM. and Conn, H.O.: Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. New England Journal of Medicine 281:407 (1969)CrossRefGoogle Scholar
  19. Fazekas, J.F.; Ticktin, H.E.; Ehrmantraut, W.R. and Alman, R. W.: Cerebral metabolism in hepatic insufficiency. American Journal of Medicine 21:843 (1956)PubMedCrossRefGoogle Scholar
  20. Fernandez, L.B.; Gonzalez, E.; Marzi, Adriana and dePaolo M. Isabel: Fecal acidorrhea. New England Journal of Medicine 284:295 (1971)CrossRefGoogle Scholar
  21. Fordtran, J.S.: Organic anions in fecal contents. New England Journal of Medicine 284:329 (1971)PubMedCrossRefGoogle Scholar
  22. Fung, W.P. and Khoo, O.T.: Treatment of chronic hepatic encephalopathy with lactulose. Medical Journal of Australia 2:160(1968)PubMedGoogle Scholar
  23. Gryboski, Joyce, D.; Zillis, J. and Ma, O.H.: A study of fecal sugars by high voltage electrophoresis. Gastroenterology 47:26 (1964)PubMedGoogle Scholar
  24. Guffens, J.M.; Pirotte, J.; Devos, J. and Delvion, J.: Comparative study of orally-induced hyperammoniaemia in chronic portacaval encephalopathy, treated with neomycin, lactulose and an association of neomycin and lactulose. To be published (1972)Google Scholar
  25. Guio, CM. and Alonso, C.R.: Clinical trial with the laxative Duphalac. Revista Clinica Espaflola 106: 145 (1967)Google Scholar
  26. Haemmerli, U.P. and Bircher, J.: Influence of lactulose treatment on non-ionic diffusion of ammonia in the dog colon. Gastroenterology 56:1163 (1969)Google Scholar
  27. Haenel, H: Mucosal and microbial utilization and splitting of lactulose and other oligosaccharides, in Symposium on Lactulose, Baden/Vienna (September 8,1969)Google Scholar
  28. Haenel, H; Feldheim, W.; Müller-Beuthow, W. and Ruttloff, H: Versuche zur Umstimmung der faekalen Flora des gesunder Erwachsenen. Zentralblatt für Bakteriologie 173:76 (1958)Google Scholar
  29. Helms, M. and Beck, K: Treatment of chronic portal systemic encephalopathy with lactulose in ten patients with cirrhosis of the liver, in Symposium on Lactulose, Baden/Vienna (September 8,1969)Google Scholar
  30. Hoffmann, K. and Bircher, J.: Veränderungen der bakteriellen Darmbesiedlung nach Laktulosegaben. Schweizerische medizinische Wochenschrift 99:608 (1969)PubMedGoogle Scholar
  31. Hoffmann, K.; Mossel, D.A.A.; Korus, W. and van de Kamer, J.H.: Untersuchungen über die Wirkungsweise der Lactulose (β-Galactosido-Fructose) im Darm. Klinische Wochenschrift 42:126 (1964)PubMedCrossRefGoogle Scholar
  32. Imler, M.; Kurtz, D.; Bockel, R. and Stahl, J: Etude comparative du traitement de l’encephalopathie porto-cave par le lactulose, les bacilles lactiques et les antibiotiques. Thérapeutique 47:237 (1971)PubMedGoogle Scholar
  33. Ingelfinger, F.J.: in Year Book of Medicine, Beeson et al. (Year Book, Chicago 1964)Google Scholar
  34. James, I.M. and Garassini, M.: Effect of lactulose on cerebral metabolism in patients with chronic portosystemic encephalopathy. Gut 12: 702 (1971)PubMedCrossRefGoogle Scholar
  35. Lande, Monique and Clot, Cl: Un correcteur des metabolitismes bactériens du colon: Traitement moderne des encéphalopathies portocaves. Semaine Thérapeutique 44:672 (1968)PubMedGoogle Scholar
  36. Lande, Monique and Clot-Paimboeuf, Cl.: Traitement des encephalopathies portocaves par le lactulose. La Presse Medicale 76:1675 (1968)Google Scholar
  37. Liem, K.S.: Biochemical report on the absorption of lactulose. N.V. Philips-Duphar, Weesp (Holland), unpublished data (1966)Google Scholar
  38. Losner, I.: Lactulose: A clinical study in a chronically constipated geriatric population. Clinical Medicine (December): 24(1969)Google Scholar
  39. MacGillivray, P.C.; Finlay, H.V.L. and Binns, T.B.: Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants. Scottish Medical Journal 4 182(1959)PubMedGoogle Scholar
  40. Ma, MM.; McLeod, J.G. and Blackburn, C.R.B.: Long-term treatment of portal systemic encephalopathy with lactulose. Australasian Annals of Medicine 18: 117 (1969)PubMedGoogle Scholar
  41. Maiolo, A.T.; Porro,G. Bianchi; Galli, C; Sessa, M. and Polli, E.E.: Brain energy metabolism in hepatic coma, in Polli Neurochemistry of hepatic coma, Vol. 4 Experimental Biology and Medicine, p. 52 (Karger, Basel 1971)Google Scholar
  42. Markoff, N.G.: Portal-systemic encephalopathy treated with lactulose. Lancet 2:281 (1966)CrossRefGoogle Scholar
  43. Mayerhofer, F. and Petuely, F.: Investigations regarding the regulation of the intestinal activity in adults with the aid of lactulose (Bifidus factor). Wiener klinische Wochenschrift 71: 865 (1959)Google Scholar
  44. Montgomery, EM. and Hudson, C.S.: Relations between rotatory power and structure in the sugar group. XXVII. Synthesis of a new disaccharide ketose (lactulose) from lactose. Journal of the American Chemical Society52:2101 (1930)CrossRefGoogle Scholar
  45. Müller, M.; Walker-Smith, J.; Shmerling, D.H.; Curtius, H.Ch. and Prader, A.: Lactulose: A gas-liquid chromatography method of determination and evaluation of its use to assess intestinal mucosal damage. Clinica chimica acta 24:45 (1969)CrossRefGoogle Scholar
  46. Muting, D.; Arfeen, N. and Schweissfurth, R.: In vitro formation of toxic protein metabolites of intestinal bacterial before and after addition of lactulose, in Symposium on Lactulose, Bden/Vienna (September 8,1969a).Google Scholar
  47. Müting, D.; Reikowski, J. and Arfeen, N.: Effect on protein metabolites and intestinal bacterial in liver cirrhosis, in Symposium on Lactulose, Baden/Vienna (September 8,1969b).Google Scholar
  48. Palma, M. de; Disanto, V. and Ferrarese, S.: Clinical trials on the prophylactic treatment of portal-systemic encephalopathy with lactulose. Puglia chirurgica 11: suppl. 6, part III, 1507(1968)Google Scholar
  49. Partiila, vonH.: Die Verwendung von Laktulose bei chronischer Obstipation (vorläufige Mitteilung). Wiener medizinische Wochenschrift 30: 557 (1969)Google Scholar
  50. Pertsiounis, S.; Egger, G. and Bircher, J.: Radiological quantitation of osmotic effect, in Symposium on Lactulose, Baden/Vienna (September 8, 1969)Google Scholar
  51. Petuely, vonF.: Der Bifidusfaktor. Deutsche medizinische Wochenschrift 82:1957(1957)PubMedCrossRefGoogle Scholar
  52. Plum, F.: The CSF in hepatic encephalopathy, in Polli Neurochemistry of hepatic coma, Vol. 4 Experimental Biology and Medicine, p. 34 (Karger, Basel 1971)Google Scholar
  53. Polli, E.: in Neurochemistry of hepatic coma Vol. 4 Experimental Biology and Medicine (Karger, Basel1971)Google Scholar
  54. Polli, E; Porro, G. Bianchi and Maiolo, A.T.: Cerebral metabolism after portacaval shunt. Lancet 7: 153 (1969)CrossRefGoogle Scholar
  55. Posner, J.B. and Plum, F: The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. Journal of Clinical Investigation 39: 1246 (1960)PubMedCrossRefGoogle Scholar
  56. Rorsman, G. and Sulg, I.: Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study. Acta medica Scandinavica 757:337(1970)Google Scholar
  57. Rottiers, R.; Egmond, J. van; Verbruggen, R.; Dierick, G. Vermeulen, A.; Groote, J. de; Standaert, L. and Demeulenaere, L.: Cirrhosis, hyperammonemia and lactulose. Overdruk uit Tijdschrift voor Gastro-Enterologie 11:123(1968)Google Scholar
  58. Rubinstein, A. and Colombo, J.P.: Nonresponsive therapeutic trial with lactulose in a case of hyperammonaemia probably due to an inborn error of metabolism, in Symposium on Lactulose, Baden/ Vienna (September 8,1969)Google Scholar
  59. Ruttloff, H; Taufel, A.; Krause, W.; Haenel, H and Täufel, K.: Die intestinal-enzymatische Spaltung von Galakto-Oligosacchariden im Darm von Tier und Mensch mit besonderer Berücksichtigung von Lactobacillus bifidus. Die Nahrung 11: 39 (1967)CrossRefGoogle Scholar
  60. Shmerling, D.H.; Walker-Smith, J.; Prader, A.; Müller, M. and Curtius, H.Ch.: Permeability of the intestinal mucosa to intact lactulose, in Symposium on Lactulose, Baden/Vienna (September 8,1969)Google Scholar
  61. Siebner, H. and Missmahl, HP.: The treatment of hepatoportal encephalopathy with lactulose. Deutsche medizinische Wochenschrift 95: 529 (1970) and German Medical Monthly 75: 529 (1970a).CrossRefGoogle Scholar
  62. Simmons, F.; Goldstein, H. and Boyle, J.S.: A controlled clinical trial of lactulose in hepatic encephalopathy. Gastroenterology 59: 827(1970)PubMedGoogle Scholar
  63. Sokoloff L: Neurophysiology and neurochemistry of coma, in Polli Neurochemistry of hepatic coma, Vol. 4 Experimental Biology and Medicine, p. 15 (Karger, Basel 1971)Google Scholar
  64. Summerskill, W.H.J.: Cerebral ammonia metabolism and hepatic coma, in Polli Neurochemistry of hepatic coma, Vol. 4 Experimental Biology and Medicine, p. 85 (Karger, Basel1971)Google Scholar
  65. Tanaka, F.: Experimental and clinical studies on digestion, absorption and utilization of lactulose. Bulletin of Kobe Medical College (October 1960)Google Scholar
  66. ten Ham, E.J.: Biochemical experiments with lactulose. N.V. Philips-Duphar Research Laboratory (August 1962)Google Scholar
  67. Watson, J.S. and Ebert, W.R.: Lactulose: A new bowel regulator. Clinical Medicine (July): 24 (1969)Google Scholar
  68. Wesselius-de Casparis, A.; Braadbaart, S.; Bergh-Bohlken, G.E. and Mimica, M.: Treatment of chronic constipation with lactulose syrup: Results of a double-blind study. Gut 9: 84 (1968)Google Scholar
  69. Wolpert, E; Phillips, S.F. and Summerskill, W.H.J.: Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid. New England Journal of Medicine 283: 159(1970)PubMedCrossRefGoogle Scholar
  70. Wolpert, E.; Phillips, S.F. and Summerskill, W.H.J.: Transport of urea and ammonia production in the human colon. Lancet2:1387(1971)PubMedCrossRefGoogle Scholar
  71. Zeegen, R.; Drinkwater J.E.; Fenton, J.C.B.; Vince, A. and Dawson, A.M.: Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy. Quarterly Journal of Medicine 39:245(1970)PubMedGoogle Scholar

Copyright information

© Adis Press 1972

Authors and Affiliations

  • G. S. Avery
    • 1
  • Elizabeth F. Davies
    • 1
  • R. N. Brogden
    • 1
  1. 1.Australiasian Drug Information ServicesTakapuna North, Auckland 9New Zealand

Personalised recommendations